| Primary |
| Myocardial Infarction |
57.1% |
| Feeling Unwell |
14.3% |
| Gout |
14.3% |
| Thrombosis Prophylaxis |
14.3% |
|
| Off Label Use |
50.0% |
| Oral Pain |
50.0% |
|
| Secondary |
| Myocardial Infarction |
17.0% |
| Atrial Fibrillation |
12.8% |
| Cardiovascular Event Prophylaxis |
8.5% |
| Thrombosis Prophylaxis |
8.5% |
| Coronary Artery Disease |
6.4% |
| Hypertension |
6.4% |
| Prophylaxis |
6.4% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Myocardial Ischaemia |
4.3% |
| Venous Thromboembolism Prophylaxis |
4.3% |
| Asphyxia |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Cerebrovascular Accident Prophylaxis |
2.1% |
| Diabetes Mellitus |
2.1% |
| Feeling Unwell |
2.1% |
| Gastric Disorder |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Gout |
2.1% |
| Hyperchlorhydria |
2.1% |
| Hyperlipidaemia |
2.1% |
|
| Haematuria |
22.2% |
| Oral Pain |
22.2% |
| Anaemia |
11.1% |
| Dehydration |
11.1% |
| Iron Deficiency Anaemia |
11.1% |
| Off Label Use |
11.1% |
| Thrombophlebitis Superficial |
11.1% |
|
| Concomitant |
| Hypertension |
37.8% |
| Product Used For Unknown Indication |
10.4% |
| Diabetes Mellitus |
7.8% |
| Prophylaxis |
6.2% |
| Coronary Artery Disease |
4.1% |
| Anticoagulant Therapy |
3.4% |
| Cardiac Disorder |
3.1% |
| Osteoporosis |
2.6% |
| Asthma |
2.3% |
| Pain |
2.3% |
| Blood Cholesterol Increased |
2.1% |
| Constipation |
2.1% |
| Myocardial Ischaemia |
2.1% |
| Parkinson's Disease |
2.1% |
| Plasma Cell Myeloma |
2.1% |
| Sleep Disorder |
2.1% |
| Thrombosis Prophylaxis |
2.1% |
| Cardiovascular Event Prophylaxis |
1.8% |
| Chest Pain |
1.8% |
| Hypokalaemia |
1.8% |
|
| Visual Impairment |
15.9% |
| Wrong Technique In Drug Usage Process |
12.7% |
| Pyrexia |
6.3% |
| Urinary Tract Infection |
6.3% |
| Weight Decreased |
6.3% |
| Diabetes Mellitus |
4.8% |
| Myalgia |
4.8% |
| Palpitations |
4.8% |
| Bicytopenia |
3.2% |
| Cytokine Release Syndrome |
3.2% |
| Deafness |
3.2% |
| Haemodilution |
3.2% |
| Hernia |
3.2% |
| Ischaemic Stroke |
3.2% |
| Lung Infection |
3.2% |
| Prostate Cancer |
3.2% |
| Speech Disorder |
3.2% |
| Thrombocytopenia |
3.2% |
| Thrombosis In Device |
3.2% |
| Vision Blurred |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Pulmonary Embolism |
33.3% |
| Thrombosis Prophylaxis |
33.3% |
|
| Shock Haemorrhagic |
100.0% |
|
